Avalo Therapeutics Statistics
Total Valuation
AVTX has a market cap or net worth of $106.00 million. The enterprise value is $27.43 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AVTX has 10.46 million shares outstanding. The number of shares has increased by 2,315.84% in one year.
Current Share Class | 10.46M |
Shares Outstanding | 10.46M |
Shares Change (YoY) | +2,315.84% |
Shares Change (QoQ) | -53.89% |
Owned by Insiders (%) | 5.26% |
Owned by Institutions (%) | 18.53% |
Float | 4.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 25.57 |
Forward PS | n/a |
PB Ratio | 4.65 |
P/TBV Ratio | 10.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 33.45 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.07.
Current Ratio | 1.42 |
Quick Ratio | 1.37 |
Debt / Equity | 0.07 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -42.52% and return on invested capital (ROIC) is -95.33%.
Return on Equity (ROE) | -42.52% |
Return on Assets (ROA) | -30.64% |
Return on Capital (ROIC) | -95.33% |
Revenue Per Employee | $43,158 |
Profits Per Employee | -$428,158 |
Employee Count | 19 |
Asset Turnover | 0.01 |
Inventory Turnover | n/a |
Taxes
Income Tax | -9,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.10% in the last 52 weeks. The beta is 1.03, so AVTX's price volatility has been similar to the market average.
Beta (5Y) | 1.03 |
52-Week Price Change | -53.10% |
50-Day Moving Average | 11.08 |
200-Day Moving Average | 10.53 |
Relative Strength Index (RSI) | 37.71 |
Average Volume (20 Days) | 59,907 |
Short Selling Information
The latest short interest is 10,057, so 0.10% of the outstanding shares have been sold short.
Short Interest | 10,057 |
Short Previous Month | 49,242 |
Short % of Shares Out | 0.10% |
Short % of Float | 0.24% |
Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, AVTX had revenue of $820,000 and -$8.14 million in losses. Loss per share was -$75.46.
Revenue | 820,000 |
Gross Profit | -9.34M |
Operating Income | -31.31M |
Pretax Income | -142.87M |
Net Income | -8.14M |
EBITDA | -31.17M |
EBIT | -31.31M |
Loss Per Share | -$75.46 |
Full Income Statement Balance Sheet
The company has $81.86 million in cash and $1.63 million in debt, giving a net cash position of $80.23 million or $7.67 per share.
Cash & Cash Equivalents | 81.86M |
Total Debt | 1.63M |
Net Cash | 80.23M |
Net Cash Per Share | $7.67 |
Equity (Book Value) | 22.73M |
Book Value Per Share | 2.18 |
Working Capital | 25.47M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -36.78M |
Capital Expenditures | n/a |
Free Cash Flow | -36.78M |
FCF Per Share | -$3.51 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | -3,818.41% |
Pretax Margin | -971.59% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,850.34% |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2,315.84% |
Shareholder Yield | -2,315.84% |
Earnings Yield | -7.67% |
FCF Yield | -34.70% |
Analyst Forecast
The average price target for AVTX is $35.00, which is 245.51% higher than the current price. The consensus rating is "Buy".
Price Target | $35.00 |
Price Target Difference | 245.51% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on December 29, 2023. It was a reverse split with a ratio of 0.0041667:1.
Last Split Date | Dec 29, 2023 |
Split Type | Reverse |
Split Ratio | 0.0041667:1 |
Scores
AVTX has an Altman Z-Score of -5.32. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.32 |
Piotroski F-Score | n/a |